241 related articles for article (PubMed ID: 29859873)
1. Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.
Subramaniam SR; Magen I; Bove N; Zhu C; Lemesre V; Dutta G; Elias CJ; Lester HA; Chesselet MF
Neurobiol Dis; 2018 Sep; 117():170-180. PubMed ID: 29859873
[TBL] [Abstract][Full Text] [Related]
2. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.
Magen I; Torres ER; Dinh D; Chung A; Masliah E; Chesselet MF
J Parkinsons Dis; 2015; 5(3):669-680. PubMed ID: 25588356
[TBL] [Abstract][Full Text] [Related]
3. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease.
Magen I; Fleming SM; Zhu C; Garcia EC; Cardiff KM; Dinh D; De La Rosa K; Sanchez M; Torres ER; Masliah E; Jentsch JD; Chesselet MF
Eur J Neurosci; 2012 Mar; 35(6):870-82. PubMed ID: 22356593
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Carnosine Mitigates α-Synuclein Pathology and Motor Dysfunction in the Thy1-aSyn Mouse Model of Parkinson's Disease.
Brown JM; Baker LS; Seroogy KB; Genter MB
ACS Chem Neurosci; 2021 Jul; 12(13):2347-2359. PubMed ID: 34138535
[TBL] [Abstract][Full Text] [Related]
5. Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.
Grant LM; Richter F; Miller JE; White SA; Fox CM; Zhu C; Chesselet MF; Ciucci MR
Behav Neurosci; 2014 Apr; 128(2):110-21. PubMed ID: 24773432
[TBL] [Abstract][Full Text] [Related]
6. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.
Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF
Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.
Torres ERS; Stanojlovic M; Zelikowsky M; Bonsberger J; Hean S; Mulligan C; Baldauf L; Fleming S; Masliah E; Chesselet MF; Fanselow MS; Richter F
Neurobiol Dis; 2021 Oct; 158():105478. PubMed ID: 34390837
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.
Fleming SM; Salcedo J; Hutson CB; Rockenstein E; Masliah E; Levine MS; Chesselet MF
Neuroscience; 2006 Nov; 142(4):1245-53. PubMed ID: 16934409
[TBL] [Abstract][Full Text] [Related]
9. Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-Synuclein.
Schidlitzki A; Stanojlovic M; Fournier C; Käufer C; Feja M; Gericke B; Garzotti M; Welford RWD; Steiner MA; Angot E; Richter F
Mov Disord; 2023 Jun; 38(6):1044-1055. PubMed ID: 37050861
[TBL] [Abstract][Full Text] [Related]
10. Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.
Wang L; Magen I; Yuan PQ; Subramaniam SR; Richter F; Chesselet MF; Taché Y
Neurogastroenterol Motil; 2012 Sep; 24(9):e425-36. PubMed ID: 22779732
[TBL] [Abstract][Full Text] [Related]
11. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.
Fleming SM; Tetreault NA; Mulligan CK; Hutson CB; Masliah E; Chesselet MF
Eur J Neurosci; 2008 Jul; 28(2):247-56. PubMed ID: 18702696
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Carnosine Intervention in the Thy1-aSyn Mouse Model of Parkinson's Disease.
Bermúdez ML; Seroogy KB; Genter MB
Neuroscience; 2019 Jul; 411():270-278. PubMed ID: 31125602
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
[TBL] [Abstract][Full Text] [Related]
15. Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits.
Hatami A; Chesselet MF
Curr Top Behav Neurosci; 2015; 22():303-30. PubMed ID: 25218491
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice.
Cuvelier E; Méquinion M; Leghay C; Sibran W; Stievenard A; Sarchione A; Bonte MA; Vanbesien-Mailliot C; Viltart O; Saitoski K; Caron E; Labarthe A; Comptdaer T; Semaille P; Carrié H; Mutez E; Gressier B; Destée A; Chartier-Harlin MC; Belarbi K
Front Mol Neurosci; 2018; 11():321. PubMed ID: 30333721
[TBL] [Abstract][Full Text] [Related]
17. Intranasal carnosine attenuates transcriptomic alterations and improves mitochondrial function in the Thy1-aSyn mouse model of Parkinson's disease.
Bermúdez ML; Skelton MR; Genter MB
Mol Genet Metab; 2018 Nov; 125(3):305-313. PubMed ID: 30146452
[TBL] [Abstract][Full Text] [Related]
18. A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.
Richter F; Subramaniam SR; Magen I; Lee P; Hayes J; Attar A; Zhu C; Franich NR; Bove N; De La Rosa K; Kwong J; Klärner FG; Schrader T; Chesselet MF; Bitan G
Neurotherapeutics; 2017 Oct; 14(4):1107-1119. PubMed ID: 28585223
[TBL] [Abstract][Full Text] [Related]
19. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
[TBL] [Abstract][Full Text] [Related]
20. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.
Fleming SM; Mulligan CK; Richter F; Mortazavi F; Lemesre V; Frias C; Zhu C; Stewart A; Gozes I; Morimoto B; Chesselet MF
Mol Cell Neurosci; 2011 Mar; 46(3):597-606. PubMed ID: 21193046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]